I

IDXX

IDXX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
IDXX Live QuoteReal-time
$689.65
+$136.17(+24.60%)1M
Day Range$686.33 – $698.79
Open$698.79
Previous Close$698.47
Volume395.9K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$54.33B
P/E Ratio (TTM)46.5
Forward P/E41.1
EPS (TTM)$14.84
Price to Book29.4
Dividend Yield0.65%
Beta (Volatility)1.54
IndustryDIAGNOSTICS & RESEARCH
52-Week RangeCurrent: $689.65 (70%)
Low: $500.61High: $769.98
Wall Street Consensus
Strong Buy
Analyst Rating
4.8/ 5.0
Target Price
$717.17+378.1% upside

Insider Buys

0

$0

Insider Sales

25

$108.68M

Total Volume

$108.68M

25 transactions

Net Activity

$108.68M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Mazelsky Jonathan Jay

Exec Chair of the Board

0 buys3 sells

$51.51M total

H
2

Hunt Nimrata

EVP

0 buys5 sells

$14.82M total

F
3

Fennell George

EVP

0 buys2 sells

$11.96M total

U
4

Underberg Sharon E.

EVP, GC, Corporate Secretary

0 buys2 sells

$9.68M total

L
5

Lane Michael

EVP

0 buys2 sells

$8.02M total

Trading History
IDXX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 4, 2026

2 weeks ago

Mazelsky Jonathan Jay

Exec Chair of the Board

Insider
Sell25.1K$703.19$17.68M

Nov 4, 2026

2 weeks ago

Underberg Sharon E.

EVP, GC, Corporate Secretary

EVP
Sell8.9K$688.59$6.13M

Nov 4, 2026

2 weeks ago

Lane Michael

EVP

EVP
Sell4.0K$688.64$2.74M

Nov 4, 2026

2 weeks ago

Junius Daniel M

Dir

Director
Sell1.2K$704.07$845K

Sep 4, 2026

2 months ago

Kingsley Lawrence D

Dir

Director
Sell2.2K$532.08$1.17M

Mar 3, 2026

8 months ago

Hunt Nimrata

EVP

EVP
Sell1.8K$634.57$1.12M

Feb 26, 2026

8 months ago

Mazelsky Jonathan Jay

Pres, CEO

CEO
Sell23.3K$657.55$15.34M

Feb 26, 2026

8 months ago

Hunt Nimrata

EVP

EVP
Sell2.7K$661.54$1.78M

Feb 17, 2026

9 months ago

Erickson Michael G

EVP

EVP
Sell5.4K$627.38$3.37M

Feb 17, 2026

9 months ago

Vandebroek Sophie V.

Dir

Director
Sell1.5K$628.62$920K

Feb 10, 2026

9 months ago

Fennell George

EVP

EVP
Sell11.3K$646.72$7.34M

Nov 7, 2025

12 months ago

Hunt Nimrata

EVP

EVP
Sell9.4K$703.34$6.63M

Aug 22, 2025

15 months ago

Szostak M Anne

Dir

Director
Sell2.2K$647.33$1.42M

Aug 12, 2025

15 months ago

Erickson Michael G

EVP

EVP
Sell406$649.96$264K

Aug 11, 2025

15 months ago

Hunt Nimrata

EVP

EVP
Sell1.2K$656.53$788K

Aug 8, 2025

15 months ago

Underberg Sharon E.

EVP, GC, Corporate Secretary

EVP
Sell5.5K$651.60$3.55M

Aug 6, 2025

15 months ago

Hunt Nimrata

EVP

EVP
Sell7.1K$630.43$4.50M

Aug 6, 2025

15 months ago

Mazelsky Jonathan Jay

Pres, CEO

CEO
Sell29.3K$631.98$18.49M

Aug 6, 2025

15 months ago

Lane Michael

EVP

EVP
Sell8.4K$627.74$5.28M

May 21, 2025

18 months ago

Szostak M Anne

Dir

Director
Sell2.3K$512.97$1.18M

May 13, 2025

18 months ago

Junius Daniel M

Dir

Director
Sell2.7K$506.41$1.36M

May 9, 2025

18 months ago

Vandebroek Sophie V.

Dir

Director
Sell1.3K$491.34$628K

Feb 10, 2025

21 months ago

Fennell George

EVP

EVP
Sell10.0K$462.53$4.62M

Feb 7, 2025

21 months ago

Szostak M Anne

Dir

Director
Sell3.0K$465.95$1.40M

Nov 27, 2024

24 months ago

Vandebroek Sophie V.

Dir

Director
Sell344$420.44$145K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
IDXX Buy Conviction0%
Industry Rank#65 of 569
Volume Contribution0.7%
Total Industry Activity$16.53B

IDXX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. IDXX ranks #65 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for IDXX

Over the last 90 days, corporate insiders at IDXX (IDXX) engaged in a total of 25 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 25 were sales. The total volume of insider trading reached $108.68M.

The net insider activity for IDXX shows a net selling bias of $108.68M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Mazelsky Jonathan Jay (Pres, CEO), who traded 29.3K shares valued at $18.49M on Aug 6, 2025.

Live Market News & Developments
Aggregated real-time headlines for IDXX (IDXX)
6 updates

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors

MarketWatch2d ago

IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide

Yahoo Finance64d ago

Illumina Stock Surges 74.8% in a Year: What's Fueling the Drive?

TradingView23h ago

Idexx Labs Barks Up A Third-Quarter Beat, And Fetches Its Next Bullish Move

Investor's Business Daily18d ago

Idexx Stock: Pet Diagnostics Company Defies Industry Slump

Barron's18d ago

IDEXX Laboratories: Great Company, But Too Expensive (Rating Downgrade)

Seeking Alpha16d ago

FAQs About IDXX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for IDXX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for IDXX is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 25 sales by company executives over the last 90 days.

The CEO Conviction Index for IDXX is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.